Details for New Drug Application (NDA): 091475
✉ Email this page to a colleague
The generic ingredient in LAMIVUDINE is lamivudine; nevirapine; zidovudine. There are twenty-nine drug master file entries for this compound. Additional details are available on the lamivudine; nevirapine; zidovudine profile page.
Summary for 091475
Tradename: | LAMIVUDINE |
Applicant: | Hetero Labs Ltd Iii |
Ingredient: | lamivudine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 091475
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | 10MG/ML | ||||
Approval Date: | Oct 6, 2023 | TE: | AA | RLD: | No |
Complete Access Available with Subscription